Therapietrouw bij psychotische stoornissen: orale versus langwerkende injecteerbare antipsychotica

View at publisher Summarise with VIRAT
Authors: G. Heylens, A. AELBRECHT
Cited by: 0
References: 35

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Medication adherence in psychotic disorders: oral versus long-acting injectable antipsychotics Background: Adherence is crucial in the treatment of psychotic disorders. Non-adherent patients face an increased risk of relapse, rehospitalization, and impaired functioning. Long-acting injectable antipsychotics (LAIs) are often used to improve adherence, but the literature shows no consensus when compared to oral antipsychotics (OAs). Objective: To examine whether a difference in adherence exists between OAs and LAIs in adults with a psychotic disorder. Methods: A literature review was conducted of studies published in the past 10 years comparing adherence between OAs and LAIs. 30 studies were included, of which 2 were randomized controlled trials (RCTs). The most frequently used adherence measures were proportion of days covered (PDC) and medication possession ratio (MPR). Results: 19 studies, including 1 RCT, reported significantly better adherence with LAIs. 3 studies found no difference, while 1 study reported higher PDC scores for OAs. 7 studies showed mixed results, often depending on the type of antipsychotic: second-generation LAIs, such as paliperidone palmitate, generally outperformed OAs, whereas first-generation LAIs sometimes performed worse. The limited number of RCTs, the retrospective design of most studies, and the absence of standardized adherence measures hinder interpretation. Furthermore, the commonly used PDC threshold of 80% is not evidence-based. Conclusion: Although LAIs are associated with higher adherence than OAs in several studies, the evidence remains mixed and methodologically limited. The choice of formulation should be individualized and discussed with the patient. Large-scale, standardized research is needed to better assess adherence and refine treatment recommendations.

Fields of Study & Subjects

Medication Adherence and Compliance Schizophrenia research and treatment Psychotherapy Techniques and Applications

Publication details

Journal / source
Tijdschrift voor Geneeskunde
Publication date
31 March 2026
Language
EN